City of Hope Medical Center: Phase 1 study started recruiting, 10 planned (Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma)
City of Hope Medical Center: Phase 1 study started recruiting, 10 planned (Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma). Its enrollment of 10 is below the median of 80 (3rd percentile). Dated 22 days ago, it is in the active follow-up window. Score 35/100. As of 2026-11-05, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 10 · 3th percentile of 9,177 ClinicalTrialStartPulse records · 0.1x the median
Free preview: all 15 published fields of this record are shown below. Locked: 499 related US ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | City of Hope Medical Center |
| Sponsor type | Academic and hospital |
| Study | Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma |
| NCT ID | NCT06675123 |
| Phase | Phase 1 |
| Status | recruiting |
| Conditions | Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell Lymphoma |
| Intervention types | procedure, drug |
| Target enrollment | 10 |
| Site countries | United States |
| Posted | 2024-11-05 |
| Planned start | 2026-09-29 |
| Event | Started recruiting |
| Event date | 2026-09-29 |
| Last update posted | 2026-10-14 |
| enrollment percentile | 3th of 9,177 (median 80, 0.1x median) |
| Peer records CSV (500 US records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch City of Hope Medical Center
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of US records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock City of Hope Medical Center + 500 US peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-14
- Data refreshed: 2026-11-05
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (US first): Sanofi · Pfizer · National Institute of Arthritis and Musculoskeletal and Skin · Apple Inc. · National Institutes of Health Clinical Center (CC) · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Thu, 05 Nov 2026 08:46:16 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: City of Hope Medical Center and 2,595 US peers
- US ClinicalTrialStartPulse records like this one: 2,595
- City of Hope Medical Center's enrollment: 3rd percentile of 9,177 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every US peer: $519,000 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
35 / 100 Score
- Just started recruiting: sites, recruitment and supply are active.
What is the ClinicalTrialStartPulse record for City of Hope Medical Center?
City of Hope Medical Center's Phase 1 study (NCT06675123) in Recurrent Mantle Cell Lymphoma, first posted 2024-11-05: started recruiting (2026-09-29), in an update posted 2026-10-14.
How does City of Hope Medical Center compare to other ClinicalTrialStartPulse records?
Its enrollment of 10 is below the median (3th percentile); smaller records often move faster and face less competition. It is 22 days old, still within a typical 45-day follow-up window. Its Score of 35/100 is modest; treat it as background rather than a priority.
City of Hope Medical Center vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| City of Hope Medical Center | US | 10 | 3rd | 2026-10-14 |
| Eli Lilly and Company | US | 108 | 62nd | 2026-11-04 |
| AbbVie | US | 135 | 68th | 2026-11-04 |
| Janssen Research & Development, LLC | US | 144 | 69th | 2026-11-03 |
Related records
ClinicalTrialStartPulse: Phase 1 ClinicalTrialStartPulse: United States sites
More US public-record feeds
U.S. DOT Injury/Illness Summary Pulse in US U.S. DOT FRA Regulated Mode Major Security Events Pulse in US U.S. DOT Crossing Inventory Data Pulse in US U.S. DOT Insur - All With History Pulse in US USAC Telecom CAF Locations Obligation and Deployment by Speed Tier Data Pul in US U.S. CDC 2022 Final Assisted Reproductive Technology Summary Pulse in US U.S. DOT Rail Equipment Accident/Incident Data Subset Pulse in US U.S. DOT Monthly Modal Time Series Pulse in US
How to monitor City of Hope Medical Center and peer phase 1 records
Get new ClinicalTrialStartPulse records like City of Hope Medical Center by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.